2018
Pharmacological Intervention to Modulate HDL: What Do We Target?
Woudberg NJ, Pedretti S, Lecour S, Schulz R, Vuilleumier N, James RW, Frias MA. Pharmacological Intervention to Modulate HDL: What Do We Target? Front Pharmacol. 2018 Jan 22;8:989
2018, Peer Reviewed articles
Sphingosine-1-phosphate (S1P) activates STAT3 to protect against de novo acute heart failure (AHF).
Deshpande GP, Imamdin A, Lecour S, Opie LH. Sphingosine-1-phosphate (S1P) activates STAT3 to protect against de novo acute heart failure (AHF). Life Sci. 2018 Mar 1;196:127-132
2018, Peer reviewed articles
The SAFE pathway for cardioprotection: is this a promising target?
Hadebe N, Cour M, Lecour S. Basic Res Cardiol. The SAFE pathway for cardioprotection: is this a promising target? 2018 Jan 15;113(2):9.
2018, Peer Reviwed articles
Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology.
Sluijter JPG, Davidson SM, Boulanger CM, Buzás EI, de Kleijn DPV, Engel FB, Giricz Z, Hausenloy DJ, Kishore R, Lecour S, Leor J, Madonna R, Perrino C, Prunier F, Sahoo S, Schiffelers RM, Schulz R, Van Laake LW, Ytrehus K, Ferdinandy P. Cardiovasc Res. Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology. 2018 Jan 1;114(1):19-34
2018, Peer Reviewed articles